COMMUNIQUÉS West-GlobeNewswire

Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial
26/06/2019
Gemcabene safely lowered serum triglycerides (TGs), the primary endpoint, in a subset of FPLD patients LIVONIA, Mich., June 26, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP) today announced top-line [...]
BioSyent Announces Withdrawal of Health Canada Submissions for Cardiovascular Products
26/06/2019
TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) announces that it has informed Health Canada that it will be withdrawing its New Drug Submissions for two cardiovascular products, [...]
Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment
26/06/2019
MINNEAPOLIS, Minn., June 26, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) (“Predictive Oncology” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug [...]
Daré Bioscience Completes Recruitment in Pre-Pivotal Trial Of Monthly Woman-Controlled, Hormone-Free Contraceptive Candidate, Ovaprene®
26/06/2019
Ovaprene has the Potential to be the First FDA-Approved Monthly, Self-Administered, Hormone-Free Contraceptive SAN DIEGO, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women [...]
US Patent Office Issues New Transplant Patent to CareDx
26/06/2019
CareDx continues to lead innovation in transplantation BRISBANE, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and [...]
Kaleido Biosciences to Highlight Chemistry-Driven Approach at Microbiome Movement – Drug Development Summit
26/06/2019
Members of leadership team to participate in sessions discussing the role of the microbiome in human disease Summit coincides with World Microbiome Day: June 27, 2019 LEXINGTON, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- [...]
Abeona Therapeutics Appoints Dr. Victor Paulus Senior Vice President of Regulatory Affairs
26/06/2019
NEW YORK and CLEVELAND, June 26, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Victor Paulus, Ph.D. as Senior [...]
AZTherapies to Present at Maxim Group’s Conference on Alzheimer’s Disease
26/06/2019
Presentation to highlight Company’s late-stage clinical program and unique approach to neuroinflammation and the treatment of early Alzheimer’s disease BOSTON, June 26, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc. , a [...]
ProMIS Neurosciences Closing Private Placement
26/06/2019
NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, June 26, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on [...]
XBiotech annonce que le Dr Alice Gottlieb dirigera la prochaine étude de phase 2 sur le bermekimab pour le traitement de l'hidradénite suppurée
26/06/2019
AUSTIN, Texas, 26 juin 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) annonce qu'Alice Gottlieb, M.D., Ph.D., dirigera la prochaine étude de phase 2 de la société portant sur l'hidradénite suppurée (HS). Le Dr [...]
Biohit Colonview Quick Test product improvement – a new Control reagent
26/06/2019
Biohit Oyj Press release 26.6.2019 at 14.15 local time (EEST) Biohit Colonview® quick test is now available with a control reagent. Biohit ColonView QT Control (Cat. No. 602390) is intended as a positive quality control [...]
Finnish Spinal Cord Injury Rehabilitation Research Using Nexstim SmartFocus Technology Receives Significant Funding from Wings for Life Foundation
26/06/2019
Press Release, Helsinki, 26 June 2019 at 2.15 pm (EET) Finnish Spinal Cord Injury Rehabilitation Research Using Nexstim SmartFocus TM Technology Receives Significant Funding from Wings for Life Foundation Nexstim Plc ( [...]
Amunix Pharmaceuticals Announces the Appointment of Dr. Bryan Irving as Chief Scientific Officer
26/06/2019
MOUNTAIN VIEW, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on enabling the promise of potent immune-activating biotherapeutics in solid tumors, [...]
Akcea and Ionis Announce Upcoming Data Presentations at the 5th European Academy of Neurology Annual Congress
26/06/2019
Multiple clinical presentations focus on the long-term clinical benefits of treatment with TEGSEDI® (inotersen) BOSTON and CARLSBAD, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an [...]
Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVAᵀᴹ (CR845/difelikefalin) for Pruritus in Patients with Primary Biliary Cholangitis (PBC)
26/06/2019
Completed Phase 1 trial in patients with hepatic impairment established Oral KORSUVA tablet strength STAMFORD, Conn., June 26, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company [...]
Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency
26/06/2019
LEXINGTON, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Teleflex Announces Expanded Nationwide Coverage for the UroLift System for Patients with Enlarged Prostate
26/06/2019
Coverage Decision by Anthem Increases Access to Minimally Invasive Treatment, Offering Patients Rapid, Durable Symptom Relief WAYNE, Pa., June 26, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today [...]
Steven A. Schwartz Joins Exactus Board of Directors
26/06/2019
DELRAY BEACH, Fla., June 26, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) – a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, is pleased to announce the appointment of Steven [...]
Philips completes cancellation of 30.0 million shares
26/06/2019
June 26, 2019 Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 30,000,000 of its shares. The cancelled shares were acquired as part of Philips’ [...]

Pages